Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency

Hormone and Metabolic Research

Volumn 38, Issue 1, 2006, Pages 16-21

  Benedini, Stefano ^a,c   Dalle Carbonare, L ^a   Albiger, N ^a   Scanarini, M ^b   Bilora, F ^a   Petrobelli, F ^a   Giannini, S ^a   Mantero, F ^a   Scaroni, C ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c Ospedale 105   (Italy)

Author keywords

Body fat mass; Endothelial function; Hypopituitarism; Insulin sensitivity; Lipid metabolism

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; RECOMBINANT GROWTH HORMONE; TRIACYLGLYCEROL;

ADULT; ADULT DISEASE; ADULTHOOD; ARM BLOOD FLOW; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BODY COMPOSITION; BODY FAT; BODY WEIGHT; BONE DENSITY; BRACHIAL ARTERY; CAROTID ARTERY; CAROTID ARTERY INTIMA MEDIA THICKNESS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; FEMALE; FLOW MEDIATED VASODILATATION; GLUCOSE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPOPITUITARISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; LIPID BLOOD LEVEL; MALE; METABOLISM; ONSET AGE; PRIORITY JOURNAL; SHORT COURSE THERAPY; THICKNESS; TRIACYLGLYCEROL BLOOD LEVEL; VASODILATATION;

ADULT; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BODY MASS INDEX; BONE DENSITY; FEMALE; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; INSULIN RESISTANCE; MALE; MIDDLE AGED; TRIGLYCERIDES; TUNICA INTIMA;

EID: 33645744658     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-924970     Document Type: Article

References (22)

1. Consensus Guidelines for the Diagnosis and Treatment of Adults with Growth Hormone Deficiency. Summary Statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J Clin Endocrinol Metab 1998; 98: 379-381
2. Carroll PV, Christ ER, Bengtsson B-Å, Carlsson L, Christiansen JS et al. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A Review. J Clin Endocrinol Metab 1998; 83: 382-395
3. Holmes SJ, Economou G, Whitehouse RW, Adams JE, Shalet SM. Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Metab 1994; 78: 669-674
4. Shahi M, Beshyah SA, Hackett D, Sharp PS, Johnston DG, Foale RA. Myocardial dysfunction in treated adult hypopituitarism: a possible explanation for increased cardiovascular mortality. Br Heart J 1992; 67:92-96
5. Rosen T, Bengtsson B-Å. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990; 336: 285-288
6. Beshyah SA, Johnston DG. Cardiovascular disease and risk factors in adults with hypopituitarism. Clin Endocrinol 1999; 50: 1-15
7. Johansson JO, Fowelin J, Landin K, Lager I, Bengtsson BA. Growth hormone-deficient adults are insulin resistant. Metab Clin Exp 1995; 44: 1126-1129
8. Hew FL, Koschmann M, Christopher M et al. Insulin resistance in growth hormone-deficient adults: defects in glucose utilization and glycogen synthase activity. J Clin Endocrinol Metab 1996; 81: 555-564
9. De Boer H, Blok GJ, Voerman HJ, Phillips M, Schouten JA. Serum lipid levels in growth hormone-deficient men. Metab Clin Exp 1994; 43: 199-203
10. Monson JP. Long-term experience with GH replacement therapy: efficacy and safety. Eur J Endocrinol 2003; 148 Suppl 2: S9-S14
11. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1998; 21 (Suppl 1): S5-S19
12. Ravikumar R, Deepa R, Shanthirani C, Mohan V. Comparison of carotid intima-media thickness, arterial stiffness, and brachial artery flow mediated dilatation in diabetic and nondiabetic subjects (The Chennai Urban Population Study [CUPS-9]). Am J Cardiol 2002; 90: 702-107
13. Giannini S, D'Angelo A, Carraro G, Nobile M, Rigotti P, Bonfante L, Marchini F, Zaninotto M, Dalle Carbonare L, Sartori L, Crepaldi G. Alendronate prevents further bone loss in renal transplant recipients. J Bone Miner Res 2001; 16 (11): 2111 -2117
14. Perseghin G, Mazzaferro V, Benedini S, Pulvirenti A, Coppa J, Regalia E. Luzi L. Resting energy expenditure in diabetic and non-diabetic patients with liver cirrhosis: relationship with insulin sensitivity, and effect of liver transplantation and of immunosuppressive therapy. Am J Clin Nutr 2002; 76: 541-548
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
16. McCallum RW, Petrie JR, Dominiczak AF, Connell MC. Growth Hormone deficiency and vascular risk. Clin Endocrinol 2002; 57: 11-24
17. Twickler TB, Cramer MJM, Dallinga-Thie GM, Chapman MJ, Erkelens DW, Koppeschaar HPF. Adult-Onset Growth Ormone Deficiency: Relation of Postprandial Dyslipidemia to Premature Atherosclerosis. J Clin Endocrinol Metab 2003; 88 (6): 2479-2488
18. Bengtsson B-Å, Roger ABS, Bennmarker H, Monson JP et al. Growth hormone replacement therapy is not associated with any increase in mortality. KIMS Study Group. J Clin Endocrinol Metab 1999; 84: 3929-3935
19. Abdu TA, Elhadd TA, Buch H, Barton D, Neary R, Clayton RN. Recombinant GH replacement in hypopituitary adults improves endothelial cell function and reduces calculated absolute and relative coronary risk. Clin Endocrinol 2004; 61: 387-393
20. Colao A, Di Somma C, Rota F, Pivonello R, Cristina Savanelli M, Spiezia S, Lombardi G. Short-term effects of Growth Hormone (GH) treatment or deprivation on cardiovascular risk parameters and intima-media thickness at carotid arteries in patients with severe GH deficiency. J Clin Endocrinol Metab 2005; 25: [Epub ahead of print]
21. Misra A, Vikram NK. Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots. Nutrition 2003; 19: 457-466
22. Lattuada G, Costantino F, Caumo A, Scifo P, Ragogna F, De Cobelli F, Del Maschio A, Luzi L, Perseghin G. Reduced whole-body lipid oxidation is associated with insulin resistance, but not with intramyocellular lipid content in offspring of type 2 diabetic patients. Diabetologia 2005; 48: 741-747